TrumpRx Expands Catalog to 800 Medications Following Integration of MFN Pricing Model

The prescription drug platform TrumpRx has expanded its inventory by 160 medications, bringing its total catalog to more than 800 offerings. This update follows the platform’s integration of the Most Favored Nation (MFN) pricing model, a policy framework designed to influence how the service determines costs and manages patient access to pharmaceutical products.

The addition of these 160 drugs represents the latest phase in the platform’s ongoing growth strategy. By incorporating these medications, the service aims to adjust its pricing structures and broaden the range of treatments available to its users. The platform utilizes the MFN model to align its drug costs with international benchmarks, a mechanism that directly dictates the current expansion of its formulary and the subsequent availability of these specific prescriptions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 8, 2026

Author

GOAI